【招银国际：MSCI中国医疗指数年初至今涨11.8%，推荐买入多只医药股】1月13日，招银国际发布研报称，MSCI中国医疗指数今年初至今累计涨幅达11.8%，跑赢MSCI中国指数9.1%。医药行业显著上涨，是因去年四季度行业回调消化了估值，年初投资者配置意愿较强。 展望2026年，创新药出海趋势将长期延续。该行会重点关注已出海管线的临床进展与数据兑现等核心催化因素，推荐买入三生制药、固生堂、...
Source Link【招银国际：MSCI中国医疗指数年初至今涨11.8%，推荐买入多只医药股】1月13日，招银国际发布研报称，MSCI中国医疗指数今年初至今累计涨幅达11.8%，跑赢MSCI中国指数9.1%。医药行业显著上涨，是因去年四季度行业回调消化了估值，年初投资者配置意愿较强。 展望2026年，创新药出海趋势将长期延续。该行会重点关注已出海管线的临床进展与数据兑现等核心催化因素，推荐买入三生制药、固生堂、...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.